JP2024523495A - デンプンベースの印刷可能な材料 - Google Patents

デンプンベースの印刷可能な材料 Download PDF

Info

Publication number
JP2024523495A
JP2024523495A JP2023579103A JP2023579103A JP2024523495A JP 2024523495 A JP2024523495 A JP 2024523495A JP 2023579103 A JP2023579103 A JP 2023579103A JP 2023579103 A JP2023579103 A JP 2023579103A JP 2024523495 A JP2024523495 A JP 2024523495A
Authority
JP
Japan
Prior art keywords
printable material
starch
less
dosage form
present disclosure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023579103A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024523495A5 (https=
Inventor
ルイ、ユアン-シアン
チョウ、キート-テン
ゴクヘール、ラジーヴ
ホイスラー、オラフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roquette Freres SA
Original Assignee
Roquette Freres SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP21305967.8A external-priority patent/EP4115878A1/en
Application filed by Roquette Freres SA filed Critical Roquette Freres SA
Publication of JP2024523495A publication Critical patent/JP2024523495A/ja
Publication of JP2024523495A5 publication Critical patent/JP2024523495A5/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y10/00Processes of additive manufacturing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00Materials specially adapted for additive manufacturing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C64/00Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
    • B29C64/10Processes of additive manufacturing
    • B29C64/106Processes of additive manufacturing using only liquids or viscous materials, e.g. depositing a continuous bead of viscous material
    • B29C64/118Processes of additive manufacturing using only liquids or viscous materials, e.g. depositing a continuous bead of viscous material using filamentary material being melted, e.g. fused deposition modelling [FDM]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
JP2023579103A 2021-07-09 2022-07-07 デンプンベースの印刷可能な材料 Pending JP2024523495A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21305967.8 2021-07-09
EP21305967.8A EP4115878A1 (en) 2021-07-09 2021-07-09 Starch based printable materials
EP21209140.9 2021-11-18
EP21209140.9A EP4115877A1 (en) 2021-07-09 2021-11-18 Starch based printable materials
PCT/EP2022/069012 WO2023281031A1 (en) 2021-07-09 2022-07-07 Starch based printable materials

Publications (2)

Publication Number Publication Date
JP2024523495A true JP2024523495A (ja) 2024-06-28
JP2024523495A5 JP2024523495A5 (https=) 2025-04-17

Family

ID=82703190

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023579103A Pending JP2024523495A (ja) 2021-07-09 2022-07-07 デンプンベースの印刷可能な材料

Country Status (6)

Country Link
US (1) US20240226016A1 (https=)
EP (1) EP4366706B1 (https=)
JP (1) JP2024523495A (https=)
KR (1) KR20240035438A (https=)
ES (1) ES3052859T3 (https=)
WO (1) WO2023281031A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL449954A1 (pl) * 2024-10-04 2026-04-07 Uniwersytet Przyrodniczy we Wrocławiu Sposób wytwarzania biodegradowalnego materiału do druku 3D w technologii SLS
PL449955A1 (pl) * 2024-10-04 2026-04-07 Uniwersytet Przyrodniczy we Wrocławiu Sposób wytwarzania biodegradowalnego materiału do druku 3D w technologii SLS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014504305A (ja) * 2010-11-02 2014-02-20 ロケット フレール 圧縮性かつ高粘性の多糖およびポリオールの粉末
US20210077410A1 (en) * 2018-01-09 2021-03-18 Triastek, Inc. Oral drug dosage forms compromising a fixed-dose of an adhd non-stimulant and an adhd stimulant

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014504305A (ja) * 2010-11-02 2014-02-20 ロケット フレール 圧縮性かつ高粘性の多糖およびポリオールの粉末
US20210077410A1 (en) * 2018-01-09 2021-03-18 Triastek, Inc. Oral drug dosage forms compromising a fixed-dose of an adhd non-stimulant and an adhd stimulant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
D.ELGAIED-LAMOUCHI ET AL., AAPS PHARMSCITECH, vol. Vol.21:148, JPN6026012788, 2020, ISSN: 0005834677 *

Also Published As

Publication number Publication date
EP4366706B1 (en) 2025-09-03
US20240226016A1 (en) 2024-07-11
KR20240035438A (ko) 2024-03-15
ES3052859T3 (en) 2026-01-15
EP4366706C0 (en) 2025-09-03
WO2023281031A1 (en) 2023-01-12
EP4366706A1 (en) 2024-05-15

Similar Documents

Publication Publication Date Title
Dos Santos et al. Eudragit®: A versatile family of polymers for hot melt extrusion and 3D printing processes in pharmaceutics
Nyamweya Applications of polymer blends in drug delivery
Saviano et al. Poly (vinyl alcohol) 3D printed tablets: The effect of polymer particle size on drug loading and process efficiency
US20240307311A1 (en) Starch based printable materials
Pereira et al. Polymer selection for hot-melt extrusion coupled to fused deposition modelling in pharmaceutics
Giri et al. Cellulose and its derivatives for application in 3D printing of pharmaceuticals
Melocchi et al. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling
CN104208713B (zh) 用于热熔挤出的组合物以及用其制备热熔挤出产品的方法
EP3544592A1 (en) Solid pharmaceutical dosage formulations and processes
JP2016522272A (ja) 固形物の膜コーティングのための膜形成組成物
ES2992002T3 (es) Moldeo tridimensional de elución rápida, filamento para moldeo tridimensional de elución rápida y material para moldeo tridimensional de elución rápida
EP4366706B1 (en) Starch based printable materials
CN104371030A (zh) 用作热熔挤出载体的醋酸琥珀羟丙甲纤维素、热熔挤出组合物及生产热熔挤出物的方法
Muehlenfeld et al. Excipients in pharmaceutical additive manufacturing: a comprehensive exploration of polymeric material selection for enhanced 3D printing
Feng et al. Twin-screw extrusion of sustained-release oral dosage forms and medical implants
Alshammari et al. Colon-targeted 3D-Printed mesalamine tablets: Core-shell design and in vitro/ex-vivo evaluation
Muehlenfeld et al. Polymers for pharmaceutical 3D printing: printability and critical insight into material properties
Doolaanea et al. A review on physicochemical properties of polymers used as filaments in 3D-printed tablets
EP4115877A1 (en) Starch based printable materials
JP7379263B2 (ja) 結合剤
CN117615749A (zh) 基于淀粉的可打印材料
Dos Santos et al. Eudragit®: A Versatile Family of Polymers for Hot Melt Extrusion and 3D Printing Processes in Pharmaceutics. Pharmaceutics 2021, 13, 1424
Panić et al. The potential of natural products use in fused deposition modeling 3D printing of pharmaceutical dosage forms
Lauria et al. Plant polysaccharides in pharmaceutical 3D printing
JP5159091B2 (ja) 活性成分の溶出を徐放性に制御する固形製剤

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20240123

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20240126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250409

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250409

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260304

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260407